As of 2024-12-04, the EV/EBITDA ratio of Flexion Therapeutics Inc (FLXN) is -7.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FLXN's latest enterprise value is 564.21 mil USD. FLXN's TTM EBITDA according to its financial statements is -78.25 mil USD. Dividing these 2 quantities gives us the above FLXN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 17.0x | 15.4x |
| Forward P/E multiples | 15.8x - 22.8x | 18.7x |
| Fair Price | (27.36) - (29.17) | (29.35) |
| Upside | -400.0% - -419.8% | -421.8% |
| Date | EV/EBITDA |